Moldéus Karolina, Cheng Yvonne W, Wikström Anna-Karin, Stephansson Olof
Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska University Hospital and Institutet, Stockholm, Sweden.
Department of Obstetrics and Gynecology, Visby Hospital, Visby, Sweden.
PLoS One. 2017 Jul 20;12(7):e0180748. doi: 10.1371/journal.pone.0180748. eCollection 2017.
There is no apparent consensus on obstetric management, i.e., induction of labor or expectant management of women with suspected large-for-gestational-age (LGA)-fetuses.
To further examine the subject, a nationwide population-based cohort study from the Swedish Medical Birth Register in nulliparous non-diabetic women with singleton, vertex LGA (>90th centile) births, 1992-2013, was performed. Delivery of a live-born LGA infant induced at 38 completed weeks of gestation in non-preeclamptic pregnancies, was compared to those of expectant management, with delivery at 39, 40, 41, or 42 completed weeks of gestation and beyond, either by labor induction or via spontaneous labor. Primary outcome was mode of delivery. Secondary outcomes included obstetric anal sphincter injury, 5-minute Apgar<7 and birth injury. Multivariable logistic regression analysis was performed to control for potential confounding. We found that among the 722 women induced at week 38, there was a significantly increased risk of cesarean delivery (aOR = 1.44 95% CI:1.20-1.72), compared to those with expectant management (n = 44 081). There was no significant difference between the groups in regards to risk of instrumental vaginal delivery (aOR = 1.05, 95% CI:0.85-1.30), obstetric anal sphincter injury (aOR = 0.81, 95% CI:0.55-1.19), nor 5-minute Apgar<7 (aOR = 1.06, 95% CI:0.58-1.94) or birth injury (aOR = 0.82, 95% CI:0.49-1.38). Similar comparisons for induction of labor at 39, 40 or 41 weeks compared to expectant management with delivery at a later gestational age, showed increased rates of cesarean delivery for induced women.
In women with LGA infants, induction of labor at 38 weeks gestation is associated with increased risk of cesarean delivery compared to expectant management, with no difference in neonatal morbidity.
对于产科管理,即对疑似大于胎龄儿(LGA)胎儿的孕妇进行引产或期待治疗,目前尚无明确的共识。
为进一步研究该问题,我们对瑞典医学出生登记处1992 - 2013年间单胎、头位LGA(>第90百分位数)出生的未产妇非糖尿病妇女进行了一项全国性基于人群的队列研究。将非子痫前期妊娠在妊娠38周整时引产分娩活产LGA婴儿的情况与期待治疗的情况进行比较,期待治疗组在妊娠39、40、41或42周整及以后通过引产或自然分娩。主要结局是分娩方式。次要结局包括产科肛门括约肌损伤、5分钟Apgar评分<7分和出生损伤。进行多变量逻辑回归分析以控制潜在的混杂因素。我们发现,在38周引产的722名妇女中,与期待治疗组(n = 44081)相比,剖宫产风险显著增加(校正比值比[aOR]=1.44,95%置信区间[CI]:1.20 - 1.72)。两组在器械助产阴道分娩风险(aOR = 1.05,95% CI:0.85 - 1.30)、产科肛门括约肌损伤(aOR = 0.81,95% CI:0.55 - 1.19)、5分钟Apgar评分<7分(aOR = 1.06, CI:0.58 - 1.94)或出生损伤(aOR = 0.82,95% CI:0.49 - 1.38)方面无显著差异。与在更晚孕周分娩的期待治疗相比,在39、40或41周引产的类似比较显示,引产妇女的剖宫产率增加。
对于LGA婴儿的孕妇,与期待治疗相比,妊娠38周引产与剖宫产风险增加相关,新生儿发病率无差异。